Pfizer Income from Discontinued Operations 2010-2025 | PFE

Pfizer income from discontinued operations for the twelve months ending March 31, 2025 was $16M, a 176.19% decline year-over-year.

  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 173.33% decline from 2023.
  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
  • Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.

Pfizer Income from Discontinued Operations 2010-2025 | PFE

  • Pfizer annual income from discontinued operations for 2024 was $0.011B, a 173.33% decline from 2023.
  • Pfizer annual income from discontinued operations for 2023 was $-0.015B, a 350% decline from 2022.
  • Pfizer annual income from discontinued operations for 2022 was $0.006B, a 101.38% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$757.6B
Johnson & Johnson (JNJ)$377.3B
AbbVie (ABBV)$338.3B
Novo Nordisk (NVO)$307.8B
Roche Holding AG (RHHBY)$256.9B
Novartis AG (NVS)$255.7B
Merck (MRK)$210.1B
Sanofi (SNY)$119.1B
Bayer (BAYRY)$31.6B
Innoviva (INVA)$1.2B